Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005)
Clinical trial NCT01852604 · COMPLETED
Trial details
- NCT number
- NCT01852604
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2015-04-01
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.